- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06324747
Soft Tissue Stability in Immediate Implant Placement Using (VST) Versus Conventional Flap in Type II Extraction Sockets
Soft Tissue Stability in Immediate Implant Placement Using the Vestibular Socket Therapy Versus Conventional Flap in Type II Extraction Sockets in the Esthetic Zone: A Randomized Clinical Trial
This study compare between the vestibular socket therapy (VST) and the traditional mucoperiosteal flap reflection in immediate implant placement in type II extraction socket in the esthetic zone.
The technique of vestibular socket therapy (VST), introduced by Elaskry, enables the placement of implants immediately while simultaneously rehabilitating the entire socket, resulting in excellent esthetic and functional outcomes that meet the expectations of patients. VST involves socket augmentation through a minimally invasive vestibular access incision, eliminating the need for the traditional mucoperiosteal flap reflection, regardless of the extent of socket compromise.
Study Overview
Status
Intervention / Treatment
Detailed Description
Several methods have been suggested for the treatment of class 2 socket types with immediate implant placement. One such technique is the immediate dento-alveolar restoration (IDR), which involves the incorporation of a tuberosity bone graft into the buccal defect, restoring the missing buccal bone walls. However, this technique has some limitations, including the lack of graft stabilization to the host bed, the high rate of bone graft remodeling, and the limited availability of tuberosity bone when wisdom teeth are present.
In contrast, Buser D. extensively researched the early implant placement method. This approach involves extracting the tooth and then waiting for a delay period of 8-12 weeks. According to the authors, this timeframe allows for the development of ample keratinized tissues, the elimination of socket infection, and the occurrence of post-extraction bone remodeling.
In contrast, both early placement and contour augmentation procedures have demonstrated certain drawbacks. These include the collapse of socket walls in both horizontal and vertical directions after tooth extraction, the need for a lengthy treatment duration that can extend up to 8 months, the challenges of maintaining provisional restorations during this extended period, and the potential for post-restorative socket tissue recession due to the reflection of the mucoperiosteal flap . As a result, achieving a successful esthetic treatment outcome becomes difficult to predict.
The technique of vestibular socket therapy (VST), introduced by Elaskry et al. , enables the placement of implants immediately while simultaneously rehabilitating the entire socket, resulting in excellent esthetic and functional outcomes that meet the expectations of patients. VST involves socket augmentation through a minimally invasive vestibular access incision, eliminating the need for the traditional mucoperiosteal flap reflection, regardless of the extent of socket compromise .
The procedure involves making a horizontal incision in the vestibule at the base of the mucogingival junction of the extracted tooth. This is followed by implant placement without the need for a flap, grafting the compromised socket walls through the vestibular access incision. The labial bone defect, which has been grafted with a bone graft, is then protected using a cortical equine membrane, and finally, the socket opening is sealed with a customized healing collar.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Cairo
-
Cairo, New Cairo, Egypt
- The British University in Egypt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hopeless maxillary tooth in the esthetic region missing coronal tooth structure
- Type II socket (deficient labial plate of bone and intact overlying soft tissues)
- Adequate palatal bone, ≥ 3 mm apical bone to engage the immediately placed implants
Exclusion Criteria:
- Smokers
- Pregnant women
- Patients with systemic diseases
- History of chemotherapy or radiotherapy within the past 2 years.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Control group
Control group will have a full thickness flap, followed by an immediate implant placement using a surgical guide.
Then a guided bone regeneration will be achieved by bone graft (autogenous bone chips and xenograft particles and a membrane barrier 1 mm thickness will be applied.
The membrane shield then will be stabilized to the apical bone using 2 membrane tacks, customized healing abutment will be connected , then, the elevated flap will be sutured to its original position.
|
reflecting the mucoperiosteum to access the extraction socket
|
Active Comparator: Test group
Elaskary Vestibular socket therapy instruments will be used for the intervention, A 1 cm long vestibular access incision at the allocated hopeless tooth will be made at the base of the hopeless tooth to the adjacent teeth.
The vestibular pouch will then be dissected in an incisal direction exposing the total socket area and allowing direct access to the socket environment.
An immediate implant will be installed using a surgical guide.
A membrane shield 1 mm thick will be, trimmed, and tucked through the vestibular access incision starting at 1 mm beyond the socket orifice and reaching to the apical area of the socket.
The gap and/ or the defect between the implant body and the shield will then be filled with the same grafting components so the control group.
Finally, the vestibular incision will be secured with sutures.
The socket will be sealed with a customized healing abutment.
|
Vestibular socket therapy will be used for the intervention.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Soft Tissue Stability
Time Frame: 8 months
|
it will be measured digitally using the intraoral scanner. A preoperative scanning, immediate postoperative, 2 months postoperative and 8 months postoperative scanning will be done. Tool to be used: 3shape trios 4 what will be assessed:
Data will be measured in millimeters |
8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone Regeneration
Time Frame: 8 months
|
measuring the thickness of the labial plate of bone. It will be measured preoperatively, immediate postoperative to measure the amount of the augmented bone, 2 months postoperatively and 8 months post operative. Tool to be used: cone beam computed tomography (cbct) |
8 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pink Esthetic Score (PES)
Time Frame: 8 months
|
The PES is based on seven variables: mesial papilla, distal papilla, soft tissue level, soft tissue contour, alveolar process deficiency, soft tissue color and soft tissue texture.
Each variable will be assessed with a 2-1-0 score, with 2 being the best and 0 being the poorest score.
|
8 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Mohamed Shawky, BDS, The British University in Egypt
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-046
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Badly Broken Tooth in a Socket Type II Eligible to be Replaced by Immediate Implant
-
Sanford HealthNational Ataxia Foundation; Beyond Batten Disease Foundation; Pitt Hopkins Research... and other collaboratorsRecruitingMitochondrial Diseases | Retinitis Pigmentosa | Myasthenia Gravis | Eosinophilic Gastroenteritis | Multiple System Atrophy | Leiomyosarcoma | Leukodystrophy | Anal Fistula | Spinocerebellar Ataxia Type 3 | Friedreich Ataxia | Kennedy Disease | Lyme Disease | Hemophagocytic Lymphohistiocytosis | Spinocerebellar Ataxia... and other conditionsUnited States, Australia
Clinical Trials on conventional full thickness flap
-
Universidad Complutense de MadridOsteology FoundationRecruiting
-
Al-Azhar UniversityCompletedFull Thickness Mucoperiosteal Flap Versus Low Level Laser in Orthodontic Tooth Movement AccelerationMesial Movement of TeethEgypt
-
Semmelweis UniversityInstitut Straumann AG; Geistlich Pharma AG; Dicomlab Kft.Recruiting
-
General Public Hospital Zell am SeeUnknownGastroesophageal Reflux DiseaseAustria
-
Azienda Ospedaliera Universitaria Policlinico Paolo...Completed
-
NDO Surgical, Inc.Terminated
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universidad El Bosque, BogotáUnknownGingival Recession | Periodontal AtrophyColombia
-
NDO Surgical, Inc.Terminated
-
NDO Surgical, Inc.CompletedGastroesophageal Reflux Disease (GERD)United States, Canada